2023788-19-2, stock367G, assay98.51%, batch size9.2G

-

 EOS Med Chem (D-U-N-S Number 703 340 474) is one of TOP CREDIT supplier in chemical market. Each year, we synthesis more than 2000 new compounds, commercial 10-20 new API and Intermediates.

 

Sales Department: 16F, Zhonghai Plaza, Jinan, total of 24 people.

R&D Center: Qihe, Jinan, with 40 full-time R&D (including 2 doctors, 8 masters, and 30 bachelors), 2 QA, 2 QC, and 1 warehouse. The total number is 45 people.

This is my R&D youtube: https://youtu.be/r5cJdXKNXHk. 

GMP Factory address: Shandong Shanghe Chemical Park. 47 workers, 2 QA, 4 QC, and 1 warehouse. Total number is 54 people. 

My GMP plant, pls visit youtube: https://youtu.be/VoAKzYsgH5Q.


Contact:

Ms Sienna

E: october@eosmedchem.com ; eosmedchem@gmail.com 

Tel: 0086-19853164979

M & Whatsapp: 0086-19853164979


Name:

Tirzepatide

CAS:

2023788-19-2

Stock:

 

Water:

0.34

HS CODE

2934999099

Chemical Formula:

/

Molecular Weight:

/

MDL No.:

/

EINECS / EC No.:

/

Pubchem CID:

/

IUPAC Name:

/

Standard InchI:

/

InchI Key:

/

SMILES:

/

Appearance:

White powder

Melting Point:

161-162°

Boiling Point:

370 °C

Density (Theoretical):

0.65

Refractive Index:

1.4520 to 1.4560

Signal Word:

N/A

Hazard Statements:

N/A

Transportation Information:

N/A

Precautionary Statements:

P280-P305 P351 P338

Flash Point:

182 °C

评论

发表评论

此博客中的热门博文

EOS Drug Discovery Stock-L055

-
图片
  EOS  mainly serving new drug research and development institutions including CRO institutions and scientific research institutes. The identification of candidates and other key aspects of new drug development.Our building blocks are mainly used in drug target discovery, screening and optimization of hit compounds, screening and optimization of lead compounds, determination of clinical candidates and other key aspects of new drug R&D, which can greatly save R&D time and improve R&D efficiency.   EOS Medchem is big in: New API and Intermediates, Custom synthesis MG:  Pharma Impurity G:  New small molecule and inhibitor KG:  New drug Intermediates 100KG:  New chemical CMO   R&D Center:  4000 sq, More than 100 hoods Pilot Plant:  20000sq, 40 reactors from 5-200L Manufacturing Site:  800000sq, 40 reactors from 100-5000L Web:  www.eosmedchem.com Email:  info@eosmedchem.com ;  eosmedchem@gmail.com; R&D ...
阅读全文

EOS MedChem Stock List-R151

-
图片
    EOS Med Chem is a leading provider of innovative chemical products and services across pharmaceutical research and development and commercial manufacturing. Its core business is: A catalog of specially designed scaffolds and building blocks. custom synthesis; process development; manufacturing of key intermediates and RSM. Officially operational in 2008, EOSMed Chem is rapidly recognized for its outstanding capabilities in designing, synthesizing and supplying novel building blocks for drug discovery. Our daily monitoring of recent research and patents in pharmaceutical R&D and medicinal chemistry continues to expand our product portfolio. With a growing number of pharmaceutical R&D projects applying its products from discovery to pre-clinical and clinical research and even commercialization, EOS Med Chem has built a first-class process R&D capability, building blocks and GMP scale-up synthesis and manufacturing. It offers. / Non-GMP intermediates. The total vo...
阅读全文